ZELBORAF
- Product NDC
- 50242-090
- 11-digit product format
- 502420090
- Labeler code
- 50242
- Product ID
- 50242-090_77f36fc9-7ae6-425a-9dff-79ab4476c864
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Vemurafenib
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Genentech, Inc.
- Application
- NDA202429
- Marketing category
- NDA
- Marketing start
- 2011-08-17
- Substance
- VEMURAFENIB
- Active strength
- 240 mg/1
- Pharmacologic classes
- Cytochrome P450 1A2 Inhibitors [MoA], Kinase Inhibitor [EPC], P-Glycoprotein Inhibitors [MoA], Protein Kinase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ZELBORAF
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| VEMURAFENIB | 240 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 207SMY3FQT |
| Rxcui | 1147223, 1147228 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50242-090-02 | ZELBORAF | 112 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 112 | | 28 |
| 50242-090-02 | ZELBORAF | 1 in 1 CARTON | TABLET, FILM COATED | 1 | | 28 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| Vemurafenib | ACTIVE INGREDIENT | 207SMY3FQT | ZELBORAF (VEMURAFENIB) TABLET, FILM COATED [GENENTECH, INC.] | 12 | |
| Vemurafenib | ACTIVE MOIETY | 207SMY3FQT | ZELBORAF (VEMURAFENIB) TABLET, FILM COATED [GENENTECH, INC.] | 12 | |
| Croscarmellose sodium | INACTIVE INGREDIENT | M28OL1HH48 | ZELBORAF (VEMURAFENIB) TABLET, FILM COATED [GENENTECH, INC.] | 12 | |
| Ferric oxide red | INACTIVE INGREDIENT | 1K09F3G675 | ZELBORAF (VEMURAFENIB) TABLET, FILM COATED [GENENTECH, INC.] | 12 | |
| Hydroxypropyl cellulose (Type H) | INACTIVE INGREDIENT | RFW2ET671P | ZELBORAF (VEMURAFENIB) TABLET, FILM COATED [GENENTECH, INC.] | 12 | |
| Hypromellose acetate succinate 06081224 (3 MM2/S) | INACTIVE INGREDIENT | 6N003M473W | ZELBORAF (VEMURAFENIB) TABLET, FILM COATED [GENENTECH, INC.] | 12 | |
| Magnesium Stearate | INACTIVE INGREDIENT | 70097M6I30 | ZELBORAF (VEMURAFENIB) TABLET, FILM COATED [GENENTECH, INC.] | 12 | |
| Polyethylene glycol 3350 | INACTIVE INGREDIENT | G2M7P15E5P | ZELBORAF (VEMURAFENIB) TABLET, FILM COATED [GENENTECH, INC.] | 12 | |
| Polyvinyl alcohol | INACTIVE INGREDIENT | 532B59J990 | ZELBORAF (VEMURAFENIB) TABLET, FILM COATED [GENENTECH, INC.] | 12 | |
| Silicon dioxide | INACTIVE INGREDIENT | ETJ7Z6XBU4 | ZELBORAF (VEMURAFENIB) TABLET, FILM COATED [GENENTECH, INC.] | 12 | |
| Talc | INACTIVE INGREDIENT | 7SEV7J4R1U | ZELBORAF (VEMURAFENIB) TABLET, FILM COATED [GENENTECH, INC.] | 12 | |
| Titanium dioxide | INACTIVE INGREDIENT | 15FIX9V2JP | ZELBORAF (VEMURAFENIB) TABLET, FILM COATED [GENENTECH, INC.] | 12 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50242-090 | ZELBORAF (VEMURAFENIB) TABLET, FILM COATED [GENENTECH, INC.] | 26 | Current NDC, Legacy NDC, 2 package rows | 20241123_38eea320-7e0c-485a-bc30-98c3c45e2763.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50242-090-02 | 50242009002 | 1 BOTTLE, PLASTIC in 1 CARTON (50242-090-02) / 112 TABLET, FILM COATED in 1 BOTTLE, PLASTIC | 2015-09-08 | 0000-00-00 | No | No | Current |
| 50242-090-86 | 50242009086 | 1 BOTTLE, PLASTIC in 1 CARTON (50242-090-86) > 112 TABLET, FILM COATED in 1 BOTTLE, PLASTIC | 2014-04-10 | 0000-00-00 | Yes | No | Current |